Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project
JMIR Medical Informatics · 2025
DOI: 10.2196/65590 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIR Medical Informatics, 2025. Verfasst von Salma Malik und 14 weiteren Autor:innen. Beteiligte Einrichtung: European Clinical Research Infrastructure Network, Paris, France. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Clinical Trials as Topic, Health Information Interoperability. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Data standards are not only key to making data processing efficient but also fundamental to ensuring data interoperability. When clinical trial data are structured according to international standards, they become significantly easier to analyze, reducing the efforts required for data cleaning, preprocessing, and secondary use. A common language and a shared set of expectations facilitate interoperability between systems and devices.
Objective
The main objectives of this study were to identify commonalities and differences in clinical trial metadata, protocols, and data collection systems/items within the VACCELERATE project.
Methods
To assess the degree of interoperability achieved in the project and suggest methodological improvements, interoperable points were identified based on the core outcome areas—immunogenicity, safety, and efficacy (clinical/physiological). These points were emphasized in the development of the master protocol template and were manually compared in the following ways: (1) summaries, objectives, and end points in the protocols of 3 VACCELERATE clinical trials (EU-COVAT-1_AGED, EU-COVAT-2_BOOSTAVAC, and EU-COVPT-1_CoVacc) against the master protocol template; (2) metadata of all 3 clinical trials; and (3) evaluations from a questionnaire survey regarding differences in data management systems and structures that enabled data exchange within the VACCELERATE network.
Results
The noncommonalities identified in the protocols and metadata were attributed to differences in populations, variations in protocol design, and vaccination patterns. The detailed metadata released for all 3 vaccine trials were clearly structured using internal standards, terminology, and the general approach of Clinical Data Acquisition Standards Harmonisation (CDASH) for data collection (eg, on electronic case report forms). VACCELERATE benefited significantly from the selection of the Clinical Trials Centre Cologne as the sole data management provider. With system database development coordinated by a single individual and no need for coordination among different trial units, a high degree of uniformity was achieved automatically. The harmonized transfer of data to all sites, using well-established methods, enabled quick exchanges and provided a relatively secure means of data transfer.
Conclusions
This study demonstrated that using master protocols can significantly enhance trial operational efficiency and data interoperability, provided that similar infrastructure and data management procedures are adopted across multiple trials. To further improve data interoperability and facilitate interpretation and analysis, shared data should be structured, described, formatted, and stored using widely recognized data and metadata standards. Trial Registration EudraCT 2021-004526-29; https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-004526-29/DE/; 2021-004889-35; https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-004889-35; and 2021-004526-29; https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-004526-29
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- European Clinical Research Infrastructure Network, Paris, France.
- School of Medicine, European University Cyprus, Nicosia, Cyprus.
- Chemical Engineering Department, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia.
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland.
- Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
- Clinical Trials Centre Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany.
ORCID-Profile: Salma Malik, Zoi Pana Dorothea, Christos D Argyropoulos, Sophia Themistocleous, Alan J Macken, Olena Valdenmaiier, Frank Scheckenbach, Elena Bardach, Andrea Pfeiffer, Katherine Loens, Jordi Cano Ochando, Oliver A Cornely, Jacques Demotes-Mainard, Sergio Contrino, Gerd Felder
Zitieren
APA
Malik, S., Dorothea, Z. P., Argyropoulos, C. D., Themistocleous, S., Macken, A. J., Valdenmaiier, O., Scheckenbach, F., Bardach, E., Pfeiffer, A., Loens, K., Ochando, J. C., Cornely, O. A., Demotes-Mainard, J., Contrino, S., & Felder, G. (2025). Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project. JMIR Medical Informatics. https://doi.org/10.2196/65590
Vancouver
Malik S, Dorothea ZP, Argyropoulos CD, Themistocleous S, Macken AJ, Valdenmaiier O, et al. Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project. JMIR Medical Informatics. 2025. doi:10.2196/65590
BibTeX
@article{Malik2025,
author = {Malik, Salma and Dorothea, Zoi Pana and Argyropoulos, Christos D and Themistocleous, Sophia and Macken, Alan J and Valdenmaiier, Olena and Scheckenbach, Frank and Bardach, Elena and Pfeiffer, Andrea and Loens, Katherine and Ochando, Jordi Cano and Cornely, Oliver A and Demotes-Mainard, Jacques and Contrino, Sergio and Felder, Gerd},
title = {Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project},
journal = {JMIR Medical Informatics},
year = {2025},
doi = {10.2196/65590}
}
EUVIMED